| Drug Name: | Solifenacin |
|---|
| Drug Class: | Antimuscarinic agent |
|---|
| Mechanism of Action: | Competitive antagonist of muscarinic receptors, primarily M3 subtype |
|---|
| Use: | - Treatment of overactive bladder (OAB) symptoms
- Reduction of urinary frequency, urgency, and urge incontinence
|
|---|
| Side Effects: | - Dry mouth
- Constipation
- Blurred vision
- Urinary retention
- Dizziness
|
|---|
| Contraindications: | - Urinary retention
- Gastric retention
- Uncontrolled narrow-angle glaucoma
- Severe hepatic impairment
|
|---|
| Specialty: | - Urology
- Family Medicine
- Internal Medicine
|
|---|